(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/06/10 | 日証協 | 354,308株 | +0.25% | 144,800株 | +440.3% | 337,851株 | +22.08% | 168,341株 | +410.12% |
2016/06/03 | 日証協 | 353,408株 | +8.44% | 26,800株 | -59.94% | 276,741株 | +12.8% | 33,000株 | -40.76% |
2016/05/27 | 日証協 | 325,908株 | -24.75% | 66,900株 | -15.1% | 245,341株 | -11.57% | 55,710株 | +118.47% |
2016/05/20 | 日証協 | 433,108株 | +7.02% | 78,800株 | -41.76% | 277,438株 | +4.78% | 25,500株 | -60.26% |
2016/05/13 | 日証協 | 404,684株 | +2.4% | 135,292株 | +104.39% | 264,778株 | +4.29% | 64,160株 | +872.12% |
2016/05/06 | 日証協 | 395,192株 | -3.99% | 66,192株 | +23.24% | 253,878株 | -1.55% | 6,600株 | -69.35% |
2016/04/28 | 日証協 | 411,600株 | -2.05% | 53,708株 | -45.86% | 257,884株 | +1.55% | 21,531株 | -45.28% |
2016/04/22 | 日証協 | 420,200株 | +9.91% | 99,200株 | -32.93% | 253,947株 | +9.47% | 39,351株 | -27.57% |
2016/04/15 | 日証協 | 382,300株 | -36.22% | 147,900株 | -22.16% | 231,972株 | -39.13% | 54,331株 | -64.77% |
2016/04/08 | 日証協 | 599,390株 | +33.38% | 190,000株 | -0.96% | 381,118株 | +44.03% | 154,231株 | +114.47% |
2016/04/01 | 日証協 | 449,390株 | +6.69% | 191,838株 | +217.61% | 264,603株 | -3.99% | 71,913株 | +280.29% |
2016/03/25 | 日証協 | 421,200株 | +9.03% | 60,400株 | +0.83% | 275,593株 | -2.03% | 18,910株 | -67.03% |
2016/03/18 | 日証協 | 386,300株 | +6.77% | 59,900株 | -0.99% | 281,305株 | +6.09% | 57,352株 | +29.76% |
2016/03/11 | 日証協 | 361,800株 | +13.13% | 60,500株 | +2.72% | 265,153株 | +3.35% | 44,200株 | +68.9% |
2016/03/04 | 日証協 | 319,800株 | +12.45% | 58,900株 | -7.54% | 256,553株 | +3.96% | 26,170株 | -52.77% |
2016/02/26 | 日証協 | 284,400株 | -7.63% | 63,700株 | -60.94% | 246,773株 | +3.57% | 55,410株 | -33.74% |
2016/02/19 | 日証協 | 307,900株 | +28.72% | 163,100株 | +53% | 238,258株 | +20.36% | 83,620株 | +281.83% |
2016/02/12 | 日証協 | 239,200株 | -6.96% | 106,600株 | +294.81% | 197,953株 | -5.58% | 21,900株 | -15.44% |
2016/02/05 | 日証協 | 257,100株 | +51.77% | 27,000株 | -70.36% | 209,653株 | +27.41% | 25,900株 | -16.99% |
※株式分割は考慮していませんのでご注意ください。
Page Top